OCR Seminar Series Presentations
Developing Budgets for Research Projects with a Focus on Phase III Clinical Trials. [PDF]
Just Because You Can’t Count It Doesn’t Mean It Doesn’t Count: Doing Good Research with Qualitative Data. [PDF]
Investigator Initiated Research: Risks, Responsibilities, and Rewards [PowerPoint] . [PDF]
Investigational New Drug Applications: Two Cases [PowerPoint] . [PDF]
Optaining IND for Investigator-Initiated Study… for the first time [PDF]
Using the Internet to Conduct Research and Recruit Subjects [PDF]
Minding the p-Values and Quartiles: Data Analysis, Research Study Design and the IRB [PowerPoint] . [PDF]
Informed Consent: Moving from Readability to Comprehension [PowerPoint] . [PDF]
Radiology Research at BUMC [PowerPoint] . [PDF]
The Logistics Behind Planning for Your Radiology Research Studies at BUMC [PowerPoint] . [PDF]
Case Report Forms: A Critical Link to the Success of Your Research Study [PDF]
Reporting Unanticipated Problems and Adverse Events: A Change in Policy [PowerPoint] . [PDF]
An Interactive Approach to Good Clinical Practices (GCPs) [PowerPoint] . [PDF]
Dispelling Common Myths about the IRB [PowerPoint] . [PDF]
Accessing Data for Clinical Researchers: The Boston Medical Center Clinical Data Warehouse [PowerPoint] . [PDF]
The Right Prescription for Working with Investigational Drug Service at BMC [PowerPoint] . [PDF],
and the related Code of Federal Regulations $ ICH Guidelines [Word] . [PDF]
Fraud in Medical Research: Emphasis on Statistical Aspects [PowerPoint] . [PDF]
Who Can Consent [PowerPoint] . [PDF]
Planning for Data and Safety Monitoring: Developing Your Study-specific DSMP [PowerPoint] . [PDF]
Informed Consent: From Readability to Comprehension [PowerPoint] . [PDF]
Surviving an Audit of Your Clinical Trial [PDF]
Inclusion of Non-English Speakers in Clinical Research [PDF]
Strategies for Success with the IRB: Tips to Help Get Your Protocol Approved. [PowerPoint]
Got Data? Tips for Researchers on Completing the Data Analysis Section of the IRB Application.[PowerPoint]
